Ontogeny of small intestinal drug transporters and metabolizing enzymes based on targeted quantitative proteomicsS

Marton Kiss; Richard Mbasu; Johan Nicolaï; Karin Barnouin; Apoorva Kotian; Miriam G. Mooij; Nico Kist; Rene M.H. Wijnen; Anna Lena Ungell; Paul Cutler; Frans G.M. Russel; Saskia N. de Wildt

doi:10.1124/dmd.121.000559

Ontogeny of small intestinal drug transporters and metabolizing enzymes based on targeted quantitative proteomics^S

Marton Kiss, Richard Mbasu, Johan Nicolaï, Karin Barnouin, Apoorva Kotian, Miriam G. Mooij, Nico Kist, Rene M.H. Wijnen, Anna Lena Ungell, Paul Cutler, Frans G.M. Russel, Saskia N. de Wildt^*

^*Corresponding author for this work

Pediatric Surgery

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

5 Downloads (Pure)

Abstract

Most drugs are administered to children orally. An information gap remains on the protein abundance of small intestinal drug-metabolizing enzymes (DMEs) and drug transporters (DTs) across the pediatric age range, which hinders precision dosing in children. To explore age-related differences in DMEs and DTs, surgical leftover intestinal tissues from pediatric and adult jejunum and ileum were collected and analyzed by targeted quantitative proteomics for apical sodium–bile acid transporter, breast cancer resistance protein (BCRP), monocarboxylate transporter 1 (MCT1), multidrug resistance protein 1 (MDR1), multidrug resistance–associated protein (MRP) 2, MRP3, organic anion–transporting polypeptide 2B1, organic cation transporter 1, peptide transporter 1 (PEPT1), CYP2C19, CYP3A4, CYP3A5, UDP glucuronosyltransferase (UGT) 1A1, UGT1A10, and UGT2B7. Samples from 58 children (48 ileums, 10 jejunums, age range: 8 weeks to 17 years) and 16 adults (8 ileums, 8 jejunums) were analyzed. When comparing age groups, BCRP, MDR1, PEPT1, and UGT1A1 abundance was significantly higher in adult ileum as compared with the pediatric ileum. Jejunal BCRP, MRP2, UGT1A1, and CYP3A4 abundance was higher in the adults compared with children 0–2 years of age. Examining the data on a continuous age scale showed that PEPT1 and UGT1A1 abundance was significantly higher, whereas MCT1 and UGT2B7 abundance was lower in adult ileum as compared with the pediatric ileum. Our data contribute to the deeper understanding of the ontogeny of small intestinal drug-metabolizing enzymes and drug transporters and shows DME-, DT-, and intestinal location–specific, age-related changes. SIGNIFICANCE STATEMENT This is the first study that describes the ontogeny of small intestinal DTs and DMEs in human using liquid chromatography with tandem mass spectrometry–based targeted quantitative proteomics. The current analysis provides a detailed picture about the maturation of DT and DME abundances in the human jejunum and ileum. The presented results supply age-related DT and DME abundance data for building more accurate PBPK models that serve to support safer and more efficient drug dosing regimens for the pediatric population.

Original language	English
Pages (from-to)	1038-1046
Number of pages	9
Journal	Drug Metabolism and Disposition
Volume	49
Issue number	12
DOIs	https://doi.org/10.1124/dmd.121.000559
Publication status	Published - 1 Dec 2021

Bibliographical note

Funding Information:
This project was financed by UCB Biopharma and the Dutch Ministry of Economic Affairs by means of the PPP Allowance made available by the Top Sector Life Sciences & Health to stimulate public-private partnerships. We report that co-authors Richard Mbasu, Johan Nicolaï, Karin Barnouin, Apoorva Kotian, Nico Kist, Anna-Lena Ungell, and Paul Cutler were employees of UCB Biopharma during the course of the study. 1M.K. and R.M. contributed equally to this work and shared first authorship. dx.doi.org/10.1124/dmd.121.000559. S This article has supplemental material available at dmd.aspetjournals.org.

Publisher Copyright:
© 2021 by The Author(s)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1124/dmd.121.000559Licence: CC BY

Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative ProteomicsFinal published version, 727 KBLicence: CC BY

Cite this

Kiss, M., Mbasu, R., Nicolaï, J., Barnouin, K., Kotian, A., Mooij, M. G., Kist, N., Wijnen, R. M. H., Ungell, A. L., Cutler, P., Russel, F. G. M., & de Wildt, S. N. (2021). Ontogeny of small intestinal drug transporters and metabolizing enzymes based on targeted quantitative proteomics^S. Drug Metabolism and Disposition, 49(12), 1038-1046. https://doi.org/10.1124/dmd.121.000559

@article{1403454e780547b08fbcc2871a463613,

title = "Ontogeny of small intestinal drug transporters and metabolizing enzymes based on targeted quantitative proteomicsS",

abstract = "Most drugs are administered to children orally. An information gap remains on the protein abundance of small intestinal drug-metabolizing enzymes (DMEs) and drug transporters (DTs) across the pediatric age range, which hinders precision dosing in children. To explore age-related differences in DMEs and DTs, surgical leftover intestinal tissues from pediatric and adult jejunum and ileum were collected and analyzed by targeted quantitative proteomics for apical sodium–bile acid transporter, breast cancer resistance protein (BCRP), monocarboxylate transporter 1 (MCT1), multidrug resistance protein 1 (MDR1), multidrug resistance–associated protein (MRP) 2, MRP3, organic anion–transporting polypeptide 2B1, organic cation transporter 1, peptide transporter 1 (PEPT1), CYP2C19, CYP3A4, CYP3A5, UDP glucuronosyltransferase (UGT) 1A1, UGT1A10, and UGT2B7. Samples from 58 children (48 ileums, 10 jejunums, age range: 8 weeks to 17 years) and 16 adults (8 ileums, 8 jejunums) were analyzed. When comparing age groups, BCRP, MDR1, PEPT1, and UGT1A1 abundance was significantly higher in adult ileum as compared with the pediatric ileum. Jejunal BCRP, MRP2, UGT1A1, and CYP3A4 abundance was higher in the adults compared with children 0–2 years of age. Examining the data on a continuous age scale showed that PEPT1 and UGT1A1 abundance was significantly higher, whereas MCT1 and UGT2B7 abundance was lower in adult ileum as compared with the pediatric ileum. Our data contribute to the deeper understanding of the ontogeny of small intestinal drug-metabolizing enzymes and drug transporters and shows DME-, DT-, and intestinal location–specific, age-related changes. SIGNIFICANCE STATEMENT This is the first study that describes the ontogeny of small intestinal DTs and DMEs in human using liquid chromatography with tandem mass spectrometry–based targeted quantitative proteomics. The current analysis provides a detailed picture about the maturation of DT and DME abundances in the human jejunum and ileum. The presented results supply age-related DT and DME abundance data for building more accurate PBPK models that serve to support safer and more efficient drug dosing regimens for the pediatric population.",

author = "Marton Kiss and Richard Mbasu and Johan Nicola{\"i} and Karin Barnouin and Apoorva Kotian and Mooij, {Miriam G.} and Nico Kist and Wijnen, {Rene M.H.} and Ungell, {Anna Lena} and Paul Cutler and Russel, {Frans G.M.} and {de Wildt}, {Saskia N.}",

note = "Funding Information: This project was financed by UCB Biopharma and the Dutch Ministry of Economic Affairs by means of the PPP Allowance made available by the Top Sector Life Sciences & Health to stimulate public-private partnerships. We report that co-authors Richard Mbasu, Johan Nicola{\"i}, Karin Barnouin, Apoorva Kotian, Nico Kist, Anna-Lena Ungell, and Paul Cutler were employees of UCB Biopharma during the course of the study. 1M.K. and R.M. contributed equally to this work and shared first authorship. dx.doi.org/10.1124/dmd.121.000559. S This article has supplemental material available at dmd.aspetjournals.org. Publisher Copyright: {\textcopyright} 2021 by The Author(s)",

year = "2021",

month = dec,

day = "1",

doi = "10.1124/dmd.121.000559",

language = "English",

volume = "49",

pages = "1038--1046",

journal = "Drug Metabolism and Disposition",

issn = "0090-9556",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

number = "12",

}

TY - JOUR

T1 - Ontogeny of small intestinal drug transporters and metabolizing enzymes based on targeted quantitative proteomicsS

AU - Kiss, Marton

AU - Mbasu, Richard

AU - Nicolaï, Johan

AU - Barnouin, Karin

AU - Kotian, Apoorva

AU - Mooij, Miriam G.

AU - Kist, Nico

AU - Wijnen, Rene M.H.

AU - Ungell, Anna Lena

AU - Cutler, Paul

AU - Russel, Frans G.M.

AU - de Wildt, Saskia N.

N1 - Funding Information: This project was financed by UCB Biopharma and the Dutch Ministry of Economic Affairs by means of the PPP Allowance made available by the Top Sector Life Sciences & Health to stimulate public-private partnerships. We report that co-authors Richard Mbasu, Johan Nicolaï, Karin Barnouin, Apoorva Kotian, Nico Kist, Anna-Lena Ungell, and Paul Cutler were employees of UCB Biopharma during the course of the study. 1M.K. and R.M. contributed equally to this work and shared first authorship. dx.doi.org/10.1124/dmd.121.000559. S This article has supplemental material available at dmd.aspetjournals.org. Publisher Copyright: © 2021 by The Author(s)

PY - 2021/12/1

Y1 - 2021/12/1

N2 - Most drugs are administered to children orally. An information gap remains on the protein abundance of small intestinal drug-metabolizing enzymes (DMEs) and drug transporters (DTs) across the pediatric age range, which hinders precision dosing in children. To explore age-related differences in DMEs and DTs, surgical leftover intestinal tissues from pediatric and adult jejunum and ileum were collected and analyzed by targeted quantitative proteomics for apical sodium–bile acid transporter, breast cancer resistance protein (BCRP), monocarboxylate transporter 1 (MCT1), multidrug resistance protein 1 (MDR1), multidrug resistance–associated protein (MRP) 2, MRP3, organic anion–transporting polypeptide 2B1, organic cation transporter 1, peptide transporter 1 (PEPT1), CYP2C19, CYP3A4, CYP3A5, UDP glucuronosyltransferase (UGT) 1A1, UGT1A10, and UGT2B7. Samples from 58 children (48 ileums, 10 jejunums, age range: 8 weeks to 17 years) and 16 adults (8 ileums, 8 jejunums) were analyzed. When comparing age groups, BCRP, MDR1, PEPT1, and UGT1A1 abundance was significantly higher in adult ileum as compared with the pediatric ileum. Jejunal BCRP, MRP2, UGT1A1, and CYP3A4 abundance was higher in the adults compared with children 0–2 years of age. Examining the data on a continuous age scale showed that PEPT1 and UGT1A1 abundance was significantly higher, whereas MCT1 and UGT2B7 abundance was lower in adult ileum as compared with the pediatric ileum. Our data contribute to the deeper understanding of the ontogeny of small intestinal drug-metabolizing enzymes and drug transporters and shows DME-, DT-, and intestinal location–specific, age-related changes. SIGNIFICANCE STATEMENT This is the first study that describes the ontogeny of small intestinal DTs and DMEs in human using liquid chromatography with tandem mass spectrometry–based targeted quantitative proteomics. The current analysis provides a detailed picture about the maturation of DT and DME abundances in the human jejunum and ileum. The presented results supply age-related DT and DME abundance data for building more accurate PBPK models that serve to support safer and more efficient drug dosing regimens for the pediatric population.

AB - Most drugs are administered to children orally. An information gap remains on the protein abundance of small intestinal drug-metabolizing enzymes (DMEs) and drug transporters (DTs) across the pediatric age range, which hinders precision dosing in children. To explore age-related differences in DMEs and DTs, surgical leftover intestinal tissues from pediatric and adult jejunum and ileum were collected and analyzed by targeted quantitative proteomics for apical sodium–bile acid transporter, breast cancer resistance protein (BCRP), monocarboxylate transporter 1 (MCT1), multidrug resistance protein 1 (MDR1), multidrug resistance–associated protein (MRP) 2, MRP3, organic anion–transporting polypeptide 2B1, organic cation transporter 1, peptide transporter 1 (PEPT1), CYP2C19, CYP3A4, CYP3A5, UDP glucuronosyltransferase (UGT) 1A1, UGT1A10, and UGT2B7. Samples from 58 children (48 ileums, 10 jejunums, age range: 8 weeks to 17 years) and 16 adults (8 ileums, 8 jejunums) were analyzed. When comparing age groups, BCRP, MDR1, PEPT1, and UGT1A1 abundance was significantly higher in adult ileum as compared with the pediatric ileum. Jejunal BCRP, MRP2, UGT1A1, and CYP3A4 abundance was higher in the adults compared with children 0–2 years of age. Examining the data on a continuous age scale showed that PEPT1 and UGT1A1 abundance was significantly higher, whereas MCT1 and UGT2B7 abundance was lower in adult ileum as compared with the pediatric ileum. Our data contribute to the deeper understanding of the ontogeny of small intestinal drug-metabolizing enzymes and drug transporters and shows DME-, DT-, and intestinal location–specific, age-related changes. SIGNIFICANCE STATEMENT This is the first study that describes the ontogeny of small intestinal DTs and DMEs in human using liquid chromatography with tandem mass spectrometry–based targeted quantitative proteomics. The current analysis provides a detailed picture about the maturation of DT and DME abundances in the human jejunum and ileum. The presented results supply age-related DT and DME abundance data for building more accurate PBPK models that serve to support safer and more efficient drug dosing regimens for the pediatric population.

UR - http://www.scopus.com/inward/record.url?scp=85120989052&partnerID=8YFLogxK

U2 - 10.1124/dmd.121.000559

DO - 10.1124/dmd.121.000559

M3 - Article

C2 - 34548392

AN - SCOPUS:85120989052

SN - 0090-9556

VL - 49

SP - 1038

EP - 1046

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

IS - 12

ER -